Novo Nordisk Financial Statements
Novo Nordisk Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Novo Nordisk Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 8,261.6 | 6,857.5 | 5,351.0 |
| Gross Profit ($ mil.) | 6,327.5 | 5,161.0 | 3,896.4 |
| Operating Income ($ mil.) | 1,766.0 | 1,563.4 | 1,235.8 |
| Total Net Income ($ mil.) | 1,683.1 | 1,116.9 | 776.3 |
| Diluted EPS (Net Income) | -- | 1.73 | 1.17 |
Novo Nordisk Stock Quote & Chart
07/03/08 12:01:25 EST •
NYSE •
63.50
•
 -2.5200
•
-3.8170 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Novo Nordisk Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.26 | 3.77 | 1.54 |
| Price/Earnings Ratio | -- | 15.99 | 15.14 |
| Price/Book Ratio | 0.34 | 2.70 | 1.46 |
| Price/Cash Flow Ratio | 1.09 | 11.60 | 9.41 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Novo Nordisk Financial Ratios
Novo Nordisk Competitive Intelligence
| Eli Lilly | Sanofi-Aventis | Wyeth | |
|---|---|---|---|
| Annual Sales ($ mil.) | 18,633.5 | 43,019.0 | 22,399.8 |
| Employees | 40,600 | 99,495 | 50,527 |
| Market Cap ($ mil.) | 53,437.8 | -- | 62,653.6 |
Competitive Landscape
